28 results on '"A. Hervás Morón"'
Search Results
2. Is hypofractionation acceptable for prostate bed radiotherapy?
3. P097 - How does PSMA PET/CT influence the management of prostate cancer patients?
4. PO-2037 Hydrogel Spacer in the treatment of prostate cancer: Feasibility and Rectal Dosimetry
5. PO-1394 Adjuvant radiation therapy after radical prostatectomy
6. PO-1367 Salvage radiotherapy after prostatectomy for biochemical relapse
7. PO-1117 Clinical and pathological prognostic factors in postoperative locally advanced head and neck cancer
8. PO-1096 Long-term results of postoperative radiochemotherapy with weekly cisplatin in head and neck cancer
9. PO-1530 Interobservator variability in GTV contouring in non-spine bone metastases
10. Exogenous lipoid pneumonia secondary to Vaseline application to the tracheostomy in a laryngectomy patient: PET/CT and MR imaging findings
11. 74P - Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)
12. 72P - Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
13. MA04.01 Cemiplimab, a Human Monoclonal Anti-PD-1, Alone or in Combination with Radiotherapy: Phase 1 NSCLC Expansion Cohorts
14. 1171P - Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)
15. 1162P - Cemiplimab, a human monoclonal anti-PD-1, plus radiotherapy (RT) in advanced non-small cell lung cancer (NSCLC): Results from a phase I expansion cohort (EC 2)
16. EP-1702: Stereotactic body radiotherapy for oligometastatic and oligoprogression patients
17. EP-1654: Evaluation of tolerability in combined treatment with immune inhibitors and palliative radiotherapy
18. EP-1553: Prognostic Role of NLR after radical surgery and postoperative radiotherapy for prostate cancer
19. EP-1473: Prediction of pathologic staging with MRI after neoadjuvant chemoradiation for Rectal Cancer
20. EP-1116: Cisplatin-based chemotherapy plus radiotherapy for head and neck carcinoma
21. EP-1113: Salvage surgery after organ preservation treatment for head and neck cancer
22. EP-1114: Organ-sparing treatment in locally advanced head and neck carcinoma
23. OC-0062: Phase II trial of SBRT and hormone therapy for oligometastases in prostate cancer (SBRT-SG 05)
24. EP-1347: Treatment outcomes with hypofractionated high-dose radiation therapy for prostate cancer
25. EP-1320: Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer: Trial in progress
26. P085 - Phase II study of SBRT as treatment for oligometastases in prostate cancer (SBRT-SG 05): Trial in progress
27. EP-1311: Fertility in prostate cancer patients treated with radiation therapy
28. PO-0728: Influence of whole pelvis radiotherapy in high risk PC outcomes treated with radical intention. RECAP data base
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.